News

U-M commits $20m to four spinouts
University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.
Mead makes his way to Mobeus
Matthew Mead has resurfaced at Mobeus Equity Partners as a venture partner ten months after stepping down as chief investment officer of Mercia Technologies.
Neuspera restimulates $26m series B
Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with all investors from the first tranche returning.
Strathclyde books in Listings Ledger
Listings Ledger has spun out from the university to commercialise a real-time valuation ticker for privately-owned companies.
Centrica gives Mixergy a whirl
The energy supplier's corporate venturing subsidiary has put an undisclosed sum into Oxford's smart water boiler spinout Mixergy.
TTU’s Innovation Hub spawns 12 businesses
TTU Innovation Hub graduated six companies from its accelerator and helped its wider affiliate community secure a total of $3.5m in grant funding.
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.
Laurentian hires Haché
Robert Haché will end his tenure as vice-president of research and innovation at York University to lead Laurentian University from July.

News Continued

Jandhyala bids CoMotion farewell
Vikram Jandhyala is standing down as executive director of University of Washington’s CoMotion but will remain with the university in other capacities.
Liverpool universities grasp Sciontec
University of Liverpool, Liverpool John Moores and Liverpool City Council will launch the Sciontec Liverpool fund to drive works for the city’s $2.6bn Knowledge Quarter Liverpool project.
Glycotest captures $3m from Fosun Pharma
The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.
Maryland mulls $16m Tedco program
State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.
Passage Bio follows $116m series A trajectory
Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.
NetScientific to delist from Aim
Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login